We are live on ! Find out more
CRVO icon

CervoMed
CRVO

20 hedge funds and large institutions have $58.6M invested in CervoMed in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,261% more capital invested

Capital invested by funds: $2.48M → $58.6M (+$56.1M)

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

67% more funds holding

Funds holding: 12 → 20 (+8)

35% more ownership

Funds ownership: 5.75% → 40.75% (+35%)

Holders
20
Holders Change
+8
Holders Change %
+66.67%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
5
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$11.5M
2
AC
Armistice Capital
New York
+$9.8M
3
IC
Ikarian Capital
Texas
+$3.17M
4
SCM
Soleus Capital Management
Connecticut
+$1.69M
5
CAM
Crown Advisors Management
California
+$1.33M

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$5.53K
2
BlackRock
BlackRock
New York
-$1.12K
3
Morgan Stanley
Morgan Stanley
New York
-$27
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$20.1M +$11.5M +861,573 New
AC
2
Armistice Capital
New York
$17.1M +$9.8M +734,363 New
IC
3
Ikarian Capital
Texas
$5.53M +$3.17M +237,345 New
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$4.64M – – –
SCM
5
Soleus Capital Management
Connecticut
$2.95M +$1.69M +126,614 New
CAM
6
Crown Advisors Management
California
$2.33M +$1.33M +100,000 New
BFM
7
Boothbay Fund Management
New York
$1.61M +$921K +69,014 New
Carson Wealth (CWM LLC)
8
Carson Wealth (CWM LLC)
Nebraska
$1.38M +$278K +20,835 +54%
Renaissance Technologies
9
Renaissance Technologies
New York
$716K +$22.7K +1,700 +6%
Vanguard Group
10
Vanguard Group
Pennsylvania
$636K +$98.4K +7,376 +37%
BlackRock
11
BlackRock
New York
$508K -$1.12K -84 -0.4%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$494K +$72.9K +5,466 +35%
JGC
13
J. Goldman & Co
New York
$315K +$180K +13,500 New
Point72 Asset Management
14
Point72 Asset Management
Connecticut
$233K +$133K +10,000 New
HI
15
Hoey Investments
Pennsylvania
$25.2K – – –
CSS
16
Cubist Systematic Strategies
Connecticut
$23.1K +$13.2K +990 New
Osaic Holdings
17
Osaic Holdings
Arizona
$9.2K – – –
HI
18
Harbour Investments
Wisconsin
$1.54K – – –
Wells Fargo
19
Wells Fargo
California
$350 +$13 +1 +7%
Morgan Stanley
20
Morgan Stanley
New York
$47 -$27 -2 -50%
TRCT
21
Tower Research Capital (TRC)
New York
– -$5.53K -725 Closed

CRVO Hedge Fund Activity: Q1 2024 in Review

20 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q1 2024, worth a combined $58.6M — up 2,261% from $2.48M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CRVO positions and 1 closed out — a net gain of 8 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $11.5M. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $5.53K sold.

  • 20 institutional investors held CervoMed (CRVO) as of Q1 2024, up from 12 in Q4 2023.
  • Funds reported $58.6M of CervoMed stock for Q1 2024, up 2,261% quarter-over-quarter.
  • 9 funds opened new CervoMed positions in Q1 2024 and 1 closed out, a net change of +8 holders.
  • The largest CervoMed buyer in Q1 2024 was RA Capital Management, an estimated $11.5M added.
  • The largest CervoMed seller in Q1 2024 was Tower Research Capital (TRC), an estimated $5.53K sold.

Based on aggregated 13F filings for Q1 2024.